ENSC logo

Ensysce Biosciences, Inc. (ENSC)

Profile

Full Name

Ensysce Biosciences, Inc.

Ticker

NASDAQ: ENSC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 14, 2018

Indexes

Not included

Website

https://www.ensysce.com

Employees

7

Key Details

Price

$2.07(-1.90%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$5.21M(+133.58% YoY)

Annual EPS

-$11.45(+83.72% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.07
    ENSC price is $2.07

    30-Day Relative Volume

    1.01
    ENSC 30-day relative volume is 1.01

    Price Performance

    Price Most recent change

    -1.9%
    ENSC price was down -1.9% on Sep 15, 2025

    Price YTD change

    -74.57%
    ENSC price is down -74.57% since January 1st

    Price 1-year change

    -60%
    ENSC price is down -60% year-on-year

    Price 3-year change

    -99.82%
    ENSC price is down -99.82% over the past 3 years

    Price Range

    Price All-time high

    $86.36K
    ENSC price is currently -100.00% below its historical high of $86.36 thousand

    Price 3-year low

    $1.62
    ENSC price is currently +27.78% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $6.14M
    ENSC market capitalization is $6.14 million

    Market cap 3-year change

    -49.04%
    ENSC market capitalization is down -49.04% over the past 3 years

    Market cap All-time high

    $349.50M
    ENSC market capitalization is currently -98.24% below its historical high of $349.50 million

    Market cap sector rank

    10.74%
    ENSC market capitalization is higher than 10.74% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +293.74%
    ENSC shares outstanding is up +293.74% year-on-year

    Shares Outstanding 3-Year Change

    +27642.06%
    ENSC shares outstanding is up +27642.06% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.41
    ENSC beta is 1.41

    200-day SMA

    $3.97
    ENSC price is currently -47.86% below its 200-day simple moving average

    50-day SMA

    $2.13
    ENSC price is currently -2.93% below its 50-day simple moving average

    RSI

    45.22
    ENSC 14-day relative strength index is 45.22

    Volume

    1.01
    ENSC 30-day relative volume is 1.01

    ATR

    $0.11
    ENSC average true range is $0.11

    10-day Historical Volatility

    28.71%
    ENSC 10-day historical volatility is 28.71%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $5.21M
    ENSC annual revenue is $5.21 million

    Revenue Analysts estimate

    $5.50M
    ENSC annual revenue is currently -5.27% lower than the consensus analysts' forecast

    Revenue 1-year change

    +133.58%
    ENSC annual revenue is up +133.58% year-on-year

    Revenue Sector rank

    43.93%
    ENSC annual revenue is higher than 43.93% of companies in Healthcare sector

    EPS

    EPS

    -$11.45
    ENSC annual earnings per share is -$11.45

    EPS Analysts estimate

    -$4.32
    ENSC annual earnings per share is currently +165.05% higher than the consensus analysts' forecast

    EPS 1-year change

    +83.72%
    ENSC annual earnings per share is up +83.72% year-on-year

    EPS Sector rank

    12.09%
    ENSC annual earnings per share is higher than 12.09% of companies in Healthcare sector

    Profit

    Gross profit

    $0.00
    ENSC annual gross profit is $0.00

    Gross margin

    0.00%
    ENSC annual gross profit margin is 0.00%

    Operating profit

    -$6.73M
    ENSC annual operating income is -$6.73 million

    Operating margin

    -129.18%
    ENSC annual operating profit margin is -129.18%

    Net income

    -$7.99M
    ENSC annual net profit is -$7.99 million

    Net margin

    -153.30%
    ENSC annual net profit margin is -153.30%

    Expenses

    Total expenses

    $13.20M
    ENSC annual total expenses is $13.20 million

    Operating expenses

    $6.73M
    ENSC annual total operating expenses is $6.73 million

    Cost of goods sold

    -
    ENSC annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $0.00
    ENSC annual SGA is $0.00

    Depreciation and amortization

    -
    ENSC annual depreciation & amortization value is unknown

    Interest expense

    $0.00
    ENSC annual interest expense is $0.00

    Income tax

    $0.00
    ENSC annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$6.73M
    ENSC annual earnings before interest & taxes is -$6.73 million

    EBITDA

    -$6.73M
    ENSC annual EBITDA is -$6.73 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.60M
    ENSC annual total assets is $5.60 million

    Non current assets

    $252.50K
    ENSC annual long term assets is $252.50 thousand

    Current assets

    $5.34M
    ENSC annual total current assets is $5.34 million

    Cash and cash equivalents

    $3.50M
    ENSC annual cash & cash equivalents is $3.50 million

    Accounts receivable

    -
    ENSC annual accounts receivable value is unknown

    Inventory

    $0.00
    ENSC annual inventory is $0.00

    Liabilities

    Total liabilities

    $2.22M
    ENSC annual total liabilities is $2.22 million

    Long term liabilities

    $10.10K
    ENSC annual total long term liabilities is $10.10 thousand

    Current liabilities

    $2.21M
    ENSC annual total current liabilities is $2.21 million

    Accounts payable

    $1.36M
    ENSC annual accounts payable is $1.36 million

    Debt

    Total debt

    $287.30K
    ENSC annual total debt is $287.30 thousand

    Total debt 1-year change

    -66.39%
    ENSC annual total debt is down -66.39% year-on-year

    Long term debt

    $0.00
    ENSC annual long term debt is $0.00

    Short term debt

    $287.30K
    ENSC annual short term debt is $287.30 thousand

    Equity & Capital

    Shareholders equity

    $3.71M
    ENSC annual stockholders equity is $3.71 million

    Book value

    $3.71M
    ENSC annual book value is $3.71 million

    Retained earnings

    -$129.54M
    ENSC annual retained earnings is -$129.54 million

    Working capital

    $3.14M
    ENSC annual working capital is $3.14 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$7.50M
    ENSC annual cash flow from operations is -$7.50 million

    Cash from operations 1-year change

    +30.4%
    ENSC annual cash flow from operations is up +30.4% year-on-year

    Cash from investing

    $0.00
    ENSC annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    0%
    ENSC annual cash flow from investing activities has remained unchanged year-on-year

    Cash from financing

    $9.88M
    ENSC annual cash flow from financing activities is $9.88 million

    Cash from financing 1-year change

    +12.85%
    ENSC annual cash flow from financing activities is up +12.85% year-on-year

    CAPEX

    CAPEX

    $0.00
    ENSC annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    ENSC annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$7.50M
    ENSC annual free cash flow is -$7.50 million

    Free cash flow 1-year change

    +30.4%
    ENSC annual free cash flow is up +30.4% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    0.00%
    ENSC annual gross profit margin is 0.00%

    Operating margin

    -129.18%
    ENSC annual operating profit margin is -129.18%

    Net margin

    -153.30%
    ENSC annual net profit margin is -153.30%

    ROA & ROE

    ROA

    -192.34%
    ENSC annual return on assets is -192.34%

    ROE

    -585.43%
    ENSC annual return on equity is -585.43%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ENSC price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ENSC price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.81
    ENSC price to book ratio is 1.81

    PB ratio Sector rank

    51.6%
    ENSC price to book ratio is higher than 51.6% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.83
    ENSC price to sales ratio is 0.83

    PS ratio Sector rank

    18.69%
    ENSC price to sales ratio is higher than 18.69% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $4.34M
    ENSC enterprise value is $4.34 million

    Enterprise value Sector rank

    16.92%
    ENSC enterprise value is higher than 16.92% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.65
    ENSC EV/EBITDA is -0.65

    EV/EBITDA Sector rank

    51.39%
    ENSC EV/EBITDA is higher than 51.39% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.42
    ENSC annual current ratio is 2.42

    Quick ratio

    2.42
    ENSC annual quick ratio is 2.42

    Leverage

    Debt to equity

    0.08
    ENSC annual debt to equity ratio is 0.08

    Interest coverage ratio

    -
    ENSC annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    ENSC piotroski f-score is 3

    Altman Z-Score

    -33.10
    ENSC altman z-score is -33.10

    Analyst ratings

    Recent major analysts updates

    Sep 25, 23 HC Wainwright & Co.
    Buy
    Jul 3, 23 HC Wainwright & Co.
    Buy
    Nov 17, 22 Lake Street
    Buy
    Nov 30, 21 Lake Street
    Buy

    Institutional Ownership

    Screeners with ENSC included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Ensysce Biosciences, Inc.?
    • Does Ensysce Biosciences, Inc. pay dividends?
    • What sector is Ensysce Biosciences, Inc. in?
    • What industry is Ensysce Biosciences, Inc. in?
    • What country is Ensysce Biosciences, Inc. based in?
    • When did Ensysce Biosciences, Inc. go public?
    • Is Ensysce Biosciences, Inc. in the S&P 500?
    • Is Ensysce Biosciences, Inc. in the NASDAQ 100?
    • Is Ensysce Biosciences, Inc. in the Dow Jones?
    • When was Ensysce Biosciences, Inc.'s last earnings report?
    • When does Ensysce Biosciences, Inc. report earnings?

    What is the ticker symbol for Ensysce Biosciences, Inc.?

    The ticker symbol for Ensysce Biosciences, Inc. is NASDAQ:ENSC

    Does Ensysce Biosciences, Inc. pay dividends?

    No, Ensysce Biosciences, Inc. does not pay dividends

    What sector is Ensysce Biosciences, Inc. in?

    Ensysce Biosciences, Inc. is in the Healthcare sector

    What industry is Ensysce Biosciences, Inc. in?

    Ensysce Biosciences, Inc. is in the Biotechnology industry

    What country is Ensysce Biosciences, Inc. based in?

    Ensysce Biosciences, Inc. is headquartered in United States

    When did Ensysce Biosciences, Inc. go public?

    Ensysce Biosciences, Inc.'s initial public offering (IPO) was on March 14, 2018

    Is Ensysce Biosciences, Inc. in the S&P 500?

    No, Ensysce Biosciences, Inc. is not included in the S&P 500 index

    Is Ensysce Biosciences, Inc. in the NASDAQ 100?

    No, Ensysce Biosciences, Inc. is not included in the NASDAQ 100 index

    Is Ensysce Biosciences, Inc. in the Dow Jones?

    No, Ensysce Biosciences, Inc. is not included in the Dow Jones index

    When was Ensysce Biosciences, Inc.'s last earnings report?

    Ensysce Biosciences, Inc.'s most recent earnings report was on August 14, 2025

    When does Ensysce Biosciences, Inc. report earnings?

    The date for Ensysce Biosciences, Inc.'s next earnings report has not been announced yet
    On this page